Waterdrop Inc. reported a 72.8% year-over-year revenue increase to RMB1,448.2 million in Q2 2026 and net profit of RMB125.8 million, marking 18 consecutive profitable quarters. The insurance segment grew 80.5% year-over-year, boosted by AI technology enhancing underwriting and product innovation, including new no-health-disclosure critical illness insurance products. Waterdrop Medical Crowdfunding supported 3.82 million patients with RMB74.7 billion donated, using AI to improve risk management and fundraising assistance. The company plans to continue investing in AI to expand healthcare and financial services accessibility while maintaining steady growth in digital clinical trial solutions.
Supermicro reported a surprising Q4 gross margin of 17.6%, far above guidance, causing shares to jump. However, management revealed this margin spike was largely due to contract deferrals and one-time factors, not a permanent improvement. They foreca...
Altrova Health has signed an exclusive distribution agreement with U.S.-based Reliability Funding LLC to sell its detection, protection, and wellness products across the United States, marking its entry into the U.S. health market. The distributor wi...
US equity markets fell after a robust August jobs report increased expectations that the Federal Reserve will raise interest rates. This strong jobs data gives the Fed more flexibility to tighten monetary policy to combat inflation. The upcoming Sept...
American Electric Power (AEP) has increased its full-year 2026 operating earnings guidance to $6.25–$6.55 per share, expecting 7–8% annual growth through 2027 and over 9% compound annual growth through 2030. This optimism is driven by strong demand g...
The US Department of Energy awarded $500 million to seven battery-related companies to reduce reliance on China, which dominates the electric vehicle battery supply chain. These grants target critical areas like mineral refining and battery component...
